Madison, WI, United States of America

Subhra Bhattacharya

This inventor holds 1 USPTO granted patent. Top assignee: Cellgate, Inc.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Subhra Bhattacharya. Retrieved from https://idiyas.com/inventor/subhra-bhattacharya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Subhra Bhattacharya: Innovator in Cancer Therapy

Introduction

Subhra Bhattacharya is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of cancer therapy through her innovative research and development of novel compounds. Her work focuses on creating effective treatments that target cancer cells while minimizing harm to healthy tissues.

Latest Patents

Subhra Bhattacharya holds a patent for "Porphyrin-polyamine conjugates for cancer therapy." This patent describes porphyrin-polyamine conjugate compounds that exhibit anticancer and antitumor effects. The porphyrin moiety selectively localizes in tumors, while the polyamine moiety acts as a cytotoxic agent. The patent also outlines methods for making and using these conjugate compounds, showcasing her commitment to advancing cancer treatment.

Career Highlights

Throughout her career, Subhra has been associated with Cellgate, Inc., where she continues to work on innovative solutions for cancer therapy. Her dedication to research and development has positioned her as a key figure in the fight against cancer.

Collaborations

Subhra has collaborated with notable colleagues, including Hirak S Basu and Andrei V Blokhin. These partnerships have further enhanced her research efforts and contributed to the advancement of cancer therapies.

Conclusion

Subhra Bhattacharya's work in developing porphyrin-polyamine conjugates represents a significant advancement in cancer therapy. Her innovative approach and dedication to research continue to inspire progress in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…